Enlivex Ltd

ENLVNASDAQ · USD
0.60USD+0.12 (-1.28%)
352

Enlivex Ltd (ENLV) Option Chain

As of September 25, 2026, Enlivex Ltd is trading at $0.60, a -1.28% change from the previous close. The nearest expiration is Nov 20, 2026. Implied volatility is 671.7%. IV Rank is 81%.

Read more

Tracking the ENLV option chain helps you see every strike and expiry on Enlivex Ltd in one view, so you can quickly identify the contracts that fit your thesis and your risk. Enlivex Ltd's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ENLV options activity at a glance. Use our scanner to monitor the ENLV option chain in real time and filter for the ENLV options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ENLV stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ENLV option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ENLV stock options are being actively traded and where they are not.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Enlivex Ltd's full chain across every expiry, highlights the most liquid strikes, and lets you screen ENLV options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ENLV stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile80.56% Elevated
  • Market cap (M$)116
  • 52 weeks high-77.14%
  • 52 weeks low4.35%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$20.00
    3244.48% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-09-04
  • P/E0.02
  • Future P/E—
  • EPS (ttm)25.48
  • EPS growth next 5 years48.20%

As of September 25, 2026

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
99.276,26150.100.000.050.152.50+420.83—5.001.903.100120.73
99.5511700.150.00—0.155.00+941.672.157.004.400.17000.45
99.664700.100.00—0.107.50+1462.504.709.406.900.15060.34

As of September 25, 2026

Scan the full option chain in one place

Browse the full ENLV option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial